Status:
UNKNOWN
The Effect of Exercise Dosage on Physical Function, Cognition and Disability Following Critical Illness
Lead Sponsor:
Australian and New Zealand Intensive Care Research Centre
Collaborating Sponsors:
Monash Health
Monash University
Conditions:
Critical Illness
Eligibility:
All Genders
18-80 years
Brief Summary
Survival following a critical illness continues to improve with ongoing developments in medical management, however evidence shows that this patient group is at a high risk of suffering long term disa...
Detailed Description
Survival from a critical illness is increasing, however the long term effect on patient's quality of life and the ability for patients to return to pre-illness function is unfavourable. Exercise in th...
Eligibility Criteria
Inclusion
- \- ICU patients who have been invasively mechanically ventilated for over 24 hours
Exclusion
- Patients aged less than 18 years old
- A proven or suspected acute primary brain process that is likely to result in global impairment of conscious level or cognition (e.g. Traumatic Brain Injury, Subarachnoid Haemorrhage, stroke or hypoxic brain injury after cardiac arrest)
- Second or subsequent admission to ICU during a single hospital admission
- Death is deemed imminent and inevitable
- Participants who do no not speak English
Key Trial Info
Start Date :
March 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03413189
Start Date
March 9 2018
End Date
December 31 2023
Last Update
September 15 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Monash Medical Centre
Clayton, Victoria, Australia, 3168
2
Dandenong Hospital
Dandenong, Victoria, Australia, 3175
3
Australian and New Zealand Intensive Care Research Centre
Melbourne, Victoria, Australia, 3004